Paper · 40501403
Phenotypic Spectrum at Diagnosis of Age-Related Endotypes of Type 1 Diabetes Mellitus: A Cross-Sectional Study in China.
Zhou Q and 3 others. J Diabetes, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Phenotypic Spectrum at Diagnosis of Age-Related Endotypes of Type 1 Diabetes Mellitus: A Cross-Sectional Study in China. Papers, record 40501403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40501403
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phenotypic Spectrum at Diagnosis of Age-Related Endotypes of Type 1 Diabetes Mellitus: A Cross-Sectional Study in China.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Humans | |
| Cross-Sectional Studies | |
| Male | |
| China | |
| Female | |
| Child | |
| Adolescent | |
| Phenotype | |
| Age Factors | |
| Child, Preschool | |
| Autoantibodies | |
| Blood Glucose | |
| Glycated Hemoglobin | |
| C-Peptide | |
| Biomarkers |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZKX22052 | Nanjing Medical Science and Technology Development Fund | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,225,179 | The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients. | Sci China Life Sci | 2016 | https://conductscience.org/library/papers/27225179 | PubMed |
| 2 | 30,370,425 | Association of Race and Ethnicity With Glycemic Control and Hemoglobin A1c Levels in Youth With Type 1 Diabetes. | JAMA Netw Open | 2018 | https://conductscience.org/library/papers/30370425 | PubMed |
| 3 | 35,147,706 | Heterogeneity of Type 1 Diabetes at Diagnosis Supports Existence of Age-Related Endotypes. | Diabetes Care | 2022 | https://conductscience.org/library/papers/35147706 | PubMed |
| 4 | 36,983,604 | Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine. | J Pers Med | 2023 | https://conductscience.org/library/papers/36983604 | PubMed |
| 5 | 32,172,310 | Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. | Diabetologia | 2020 | https://conductscience.org/library/papers/32172310 | PubMed |
| 6 | 30,259,209 | The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms. | Curr Diab Rep | 2018 | https://conductscience.org/library/papers/30259209 | PubMed |
| 7 | 35,940,303 | COVID-19 induced Diabetes: A novel presentation. | Diabetes Res Clin Pract | 2022 | https://conductscience.org/library/papers/35940303 | PubMed |
| 8 | 37,337,007 | Heterogeneity and endotypes in type 1 diabetes mellitus. | Nat Rev Endocrinol | 2023 | https://conductscience.org/library/papers/37337007 | PubMed |
| 9 | 23,155,700 | Thyroid autoimmunity in 72 children with type 1 diabetes mellitus: relationship with pancreatic autoimmunity and child growth. | J Pediatr Endocrinol Metab | 2012 | https://conductscience.org/library/papers/23155700 | PubMed |
| 10 | 27,422,577 | Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose. | Diabetes Care | 2016 | https://conductscience.org/library/papers/27422577 | PubMed |
1 to 10 of 28
See all 28 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,413,288 | Transcriptomics of type 1 diabetes progression: a validation study in newly diagnosed patients. | EBioMedicine | 2026 | https://conductscience.org/library/papers/42413288 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GLUL | 2,752 | PubTator's text mining | https://conductscience.org/library/genes/2752 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40501403
GET https://conductscience.org/api/papers/v1/40501403/references?page=2